Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EVAC vs AFJK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EVAC Wins Head-to-Head Institutional Verdict (3–0 across 6 Pillars · 5–0 Matrix Metrics)

EVAC Overall Winner 6-Pillar Tally: EVAC 3 – 0 AFJK (3 Tie) Matrix Metrics: EVAC 5 – 0 AFJK

As of Nov 20, 2026, EQV Ventures Acquisition Corp. II (EVAC) is the stronger overall head-to-head candidate over Aimei Health Technology Co., Ltd (AFJK) in the Tradestie Institutional Equity Comparison Engine, winning 5–0 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). EVAC carries a Unified Composite Score of 54.7/100 (HOLD) at $10.43 (N/M Forward P/E, 0.0% operating margin), whereas AFJK carries 48.1/100 (HOLD) at $11.78 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EVAC vs AFJK
EVAC NYSE Head-to-Head Winner
EQV Ventures Acquisition Corp. II
Blank Checks
$10.43
+0.48% 1D
Market Cap $606.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 1% Vol
Unified Composite Score
54.7 / 100 HOLD
Tech 35.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 83
RSI-14: 82.5 · SMA20: $10.37 · SMA50: $10.33
AFJK US Equity
Aimei Health Technology Co., Ltd
Blank Checks
$11.78
-1.01% 1D
Market Cap $37.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.96β · 28% Vol
Unified Composite Score
48.1 / 100 HOLD
Tech 62.0 Fund 46.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.2 · SMA20: $12.13 · SMA50: $12.18

6-Pillar Scorecard Institutional Category Breakdown (EVAC 3 – 0 AFJK)

Columns: Metric · EVAC · AFJK
1. Valuation Multiples EVAC
Forward P/E N/M N/M
Trailing P/E 35.8x N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale EVAC
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) -9.8% -43.4%
TTM Revenue (USD) N/A N/A
Market Cap $606.7M $37.7M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow EVAC
Cash Generation (TTM) N/A -$100,091
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE $499,415 Net Debt (0.26x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EVAC (5) vs AFJK (0)
Institutional Metric EVAC AFJK Criterion Row Edge
Market Capitalization
Scale
$606.7M $37.7M Larger Scale EVAC
Trailing P/E Ratio
Valuation
35.8x N/M Lower Multiple EVAC
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
100% ($10–$10) 4% ($7–$130) Stronger Trend EVAC
Beta / 30D Volatility
Risk Regime
0.02β · 1% Vol 0.96β · 28% Vol Lower Realized Risk EVAC
Unified Institutional Score
Composite Signal
54.7 / 100 (HOLD) 48.1 / 100 (HOLD) Higher Composite EVAC
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) -$100,091 ($499,415 Net Debt (0.26x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EVAC +5.16 pp
EVAC: +1.16% · AFJK: -4.0%
3M Horizon EVAC +3.68 pp
EVAC: +1.76% · AFJK: -1.92%
6M Horizon EVAC +77.4 pp
EVAC: +2.91% · AFJK: -74.49%
1Y Horizon EVAC +3.31 pp
EVAC: +3.99% · AFJK: +0.68%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVAC vs AFJK. Trailing 12-month operating profitability (EVAC 0.0% vs AFJK 0.0%) and valuation multiples (EVAC N/M vs AFJK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

EVAC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
AFJK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EVAC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EVAC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AFJK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AFJK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EVAC Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $606.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AFJK Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $37.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ EVAC vs AFJK Key Questions & Quantitative Answers

As of Nov 20, 2026, EQV Ventures Acquisition Corp. II (EVAC) is the stronger overall head-to-head candidate over Aimei Health Technology Co., Ltd (AFJK) in the Tradestie Institutional Equity Comparison Engine, winning 5–0 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). EVAC carries a Unified Composite Score of 54.7/100 (HOLD) at $10.43 (N/M Forward P/E, 0.0% operating margin), whereas AFJK carries 48.1/100 (HOLD) at $11.78 (N/M Forward P/E, 0.0% operating margin). Technically, EVAC sits in a Neutral phase (RSI 82.5, UNCLASSIFIED options structure) and AFJK sits in a Neutral phase (RSI 41.2, UNCLASSIFIED options structure).

EVAC leads the Growth & Scale pillar: EVAC posts +0.0% YoY revenue growth and -9.8% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with AFJK at +0.0% YoY revenue growth and -43.4% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, EVAC generates N/A in USD-normalized revenue versus N/A for AFJK. In operating R&D and SG&A reinvestment, EVAC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AFJK.

EVAC screens cheaper on headline valuation multiples. EVAC trades at N/M Forward P/E, 35.8x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AFJK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVAC (0.0% ROE) versus AFJK (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, EVAC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 1% Vol realized risk). By comparison, AFJK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.